Analysis | Technology Platform | Turnaround Time |
---|---|---|
Peptide mapping | 1D nano LC-MS/MS with multi-enzyme digestion | up to 4 samples/week |
Protein identification | 1D nano LC-MS/MS with one enzyme digestion | 5 samples/week |
Intact protein analysis | 1D LC MS | 500 samples/week |
CoIP or pull-down - label free | 1 day, 3-Phase 2-Dimesional nano LC MS/MS, relative quantitation with spectral counting | 5 samples/week |
CoIP or pull-down -iTRAQ | 1 day, 3-Phase 2-Dimesional nano LC MS/MS, relative quantitation with spectral counting | 2 sets/week |
Germline screening | 1D nano LC-MS/MS | 24 samples/week |
Sequence variance identification | 1D nano LC-MS/MS with multi-enzyme digestion and multi-step data analysis | 1 sample/3 weeks |
Antibody identification and sequence confirmation | 1D nano LC-MS/MS with multi-enzyme digestion | up to 4 samples/week |
Unknown mAb sequencing | 1D nano LC-MS/MS with multi-enzyme digestion and multi-step data analysis | 1 sample/3 weeks |
ADC intact mass | 1D LC MS | 500 samples/week |
ADC conjugation sites/quantitation | 1D UPLC-SRM with or without internal standards | 500 samples/week |